Diabetes affects more than 40 million people in the United States, according to the American Diabetes Association. For many, ...

Please provide your email address to receive an email when new articles are posted on . In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including a new ...

MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences announces U.S. Food and Drug Administration 510(k) clearance to market Microlyte® Ag/Lidocaine, the first antimicrobial wound dressing to integrate ...

SARASOTA, Fla., June 6, 2024 /PRNewswire/ -- Omeza ®, a regenerative skincare company that develops marine-based therapies for wounds that are hard to treat, today announced completion of a ...

Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain management The new code is effective April 1, 2026 and ...

MADISON, Wis.--(BUSINESS WIRE)--Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) ...

SARASOTA, Fla., June 5, 2024 /PRNewswire/ -- Omeza®, a regenerative skincare company that develops marinebased therapies for wounds that are hard to treat, today announced completion of a multi-center ...

Cohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data reinforce a comprehensive approach to ...

MIDDLETON, Wis., Aug. 28, 2025 /PRNewswire/ -- Imbed Biosciences Inc., a leader in advanced wound care technology, today announced the launch of SAM™ PainGuard™ with Lidocaine, a groundbreaking ...